Tag: lebrikizumab
Eli Lilly: promising data on lebrikizumab
(CercleFinance.com) – Eli Lilly announces that a phase III trial has demonstrated the potential of lebrikizumab, a new monoclonal antibody inhibitor of IL-13, when combined with topical corticosteroids (TCS ),…